SIRPA and neoplasm: OAd-SIRPα-Fc and OAd-Siglec10-Fc have been shown to significantly suppress tumor growth in macrophage-rich tumor microenvironments, while OAd-TIGIT-Fc primarily enhances T cell activation (18).